Canine hemangiosarcoma originates from hematopoietic precursors with potential for endothelial differentiation

Experimental Hematology

Volumn 34, Issue 7, 2006, Pages 870-878

  Lamerato Kozicki, Angela R ^a   Helm, Karen M ^b   Jubala, Cristan M ^a   Cutter, Gary C ^c   Modiano, Jaime F ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO CANCER CENTER   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTEGRIN; BETA INTEGRIN; CD11B ANTIGEN; CD133 ANTIGEN; CD14 ANTIGEN; CD3 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; ENDOGLIN; STEM CELL FACTOR;

ANGIOSARCOMA; ANIMAL CELL; ARTICLE; BLOOD SAMPLING; BONE MARROW; CANCER DIAGNOSIS; CANCER STAGING; CELL DIFFERENTIATION; CELL SURFACE; CONTROLLED STUDY; DOG; ENDOTHELIUM CELL; FLOW CYTOMETRY; HEMANGIOBLASTOMA; HEMATOPOIETIC STEM CELL; LEUKOCYTE; NONHUMAN; PRIORITY JOURNAL; PROGENY;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; DOGS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HEMANGIOSARCOMA; IMMUNOPHENOTYPING;

CANIS FAMILIARIS;

EID: 33745213573     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2006.04.013     Document Type: Article

References (35)

1. Dickerson E.B., Thomas R., Fosmire S.P., et al. Mutations of phosphatase and tensin homolog deleted from chromosome 10 in canine hemangiosarcoma. Vet Pathol 42 (2005) 618-632
2. Frank S.A., and Nowak M.A. Cell biology: Developmental predisposition to cancer. Nature 422 (2003) 494-494
3. Schatteman G.C., and Awad O. Hemangioblasts, angioblasts, and adult endothelial cell progenitors. Anat Rec A Discov Mol Cell Evol Biol 276 (2004) 13-21
4. Huntly B.J., and Gilliland D.G. Leukaemia stem cells and the evolution of cancer-stem-cell research. Nat Rev Cancer 5 (2005) 311-321
5. Serakinci N., Guldberg P., Burns J.S., et al. Adult human mesenchymal stem cell as a target for neoplastic transformation. Oncogene 23 (2004) 5095-5098
6. Singh S.K., Hawkins C., Clarke I.D., et al. Identification of human brain tumour initiating cells. Nature 432 (2004) 396-401
7. Smith G.H. Mammary cancer and epithelial stem cells: a problem or a solution?. Breast Cancer Res 4 (2002) 47-50
8. Ingram D.A., Mead L.E., Moore D.B., Woodard W., Fenoglio A., and Yoder M.C. Vessel wall derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood 105 (2005) 2783-2786
9. Hristov M., and Weber C. Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance. J Cell Mol Med 8 (2004) 498-508
10. + cells. Ann Hematol 84 (2005) 417-422
11. + cells. Br J Haematol 115 (2001) 186-194
12. Zhao Y., Glesne D., and Huberman E. A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc Natl Acad Sci U S A 100 (2003) 2426-2431
13. Khan S.S., Solomon M.A., and McCoy Jr. J.P. Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytometry B Clin Cytom 64 (2005) 1-8
14. Ferrer L., Fondevila D., Rabanal R.M., and Vilafranca M. Immunohistochemical detection of CD31 antigen in normal and neoplastic canine endothelial cells. J Comp Pathol 112 (1995) 319-326
15. von Beust B.R., Suter M.M., and Summers B.A. Factor VIII-related antigen in canine endothelial neoplasms: an immunohistochemical study. Vet Pathol 25 (1988) 251-255
16. + blood cells. Thromb Haemost 94 (2005) 1270-1279
17. Warrington K., Hillarby M.C., Li C., Letarte M., and Kumar S. Functional role of CD105 in TGF-β1 signalling in murine and human endothelial cells. Anticancer Res 25 (2005) 1851-1864
18. Fosmire S.P., Dickerson E.B., Scott A.M., et al. Canine malignant hemangiosarcoma as a model of primitive angiogenic endothelium. Lab Invest 84 (2004) 562-572
19. Friedlander M., Brooks P.C., Shaffer R.W., Kincaid C.M., Varner J.A., and Cheresh D.A. Definition of two angiogenic pathways by distinct αv integrins. Science 270 (1995) 1500-1502
20. Soldi R., Mitola S., Strasly M., Defilippi P., Tarone G., and Bussolino F. Role of α-v/β-3 integrin in the activation of vascular endothelial growth factor receptor-2. EMBO J 18 (1999) 882-892
21. Frazer-Abel A.A., Baksh S., Fosmire S.P., et al. Nicotine activates NFATc2 and prevents cell cycle entry in T cells. J Pharmacol Exp Ther 311 (2004) 758-769
22. Jubala C.M., Wojcieszyn J.W., Valli V.E.O., et al. CD20 expression in normal canine B cells and in canine non-Hodgkin's lymphoma. Vet Pathol 42 (2005) 468-476
23. Byrne K.M., Kim H.W., Chew B.P., Reinhart G.A., and Hayek M.G. A standardized gating technique for the generation of flow cytometry data for normal canine and normal feline blood lymphocytes. Vet Immunol Immunopathol 73 (2000) 167-182
24. Gauthier M.J., Aubert I., Abrams-Ogg A., Woods J.P., and Bienzle D. The immunophenotype of peripheral blood lymphocytes in clinically healthy dogs and dogs with lymphoma in remission. J Vet Intern Med 19 (2005) 193-199
25. Reis A.B., Carneiro C.M., Carvalho M.G., et al. Establishment of a microplate assay for flow cytometric assessment and it is use for the evaluation of age-related phenotypic changes in canine whole blood leukocytes. Vet Immunol Immunopathol 103 (2005) 173-185
26. Dahlke M.H., Lauth O.S., Jager M.D., et al. In vivo depletion of hematopoietic stem cells in the rat by an anti-CD45 (RT7) antibody. Blood 99 (2002) 3566-3572
27. Shaw J.P., Basch R., and Shamamian P. Hematopoietic stem cells and endothelial cell precursors express Tie-2, CD31 and CD45. Blood Cells Mol Dis 32 (2004) 168-175
28. MacDonald V.S., Dickerson E.B., Akhtar N., and Helfand S.C. Tyrosine kinase blockade in canine hemangiosarcoma (Abstract). Vet Comp Oncol 3 (2005) 153
29. Ria R., Vacca A., Ribatti D., Di Raimondo F., Merchionne F., and Dammacco F. α(v)β(3) integrin engagement enhances cell invasiveness in human multiple myeloma. Haematologica 87 (2002) 836-845
30. Vacca A., Ria R., Presta M., et al. α(v)β(3) integrin engagement modulates cell adhesion, proliferation, and protease secretion in human lymphoid tumor cells. Exp Hematol 29 (2001) 993-1003
31. London C.A., Kisseberth W.C., Galli S.J., Geissler E.N., and Helfand S.C. Expression of stem cell factor receptor (c-kit) by the malignant mast cells from spontaneous canine mast cell tumours. J Comp Pathol 115 (1996) 399-414
32. Vernau W., and Moore P.F. An immunophenotypic study of canine leukemias and preliminary assessment of clonality by polymerase chain reaction. Vet Immunol Immunopathol 69 (1999) 145-164
33. Wong C.W., Lee A., Shientag L., et al. Apoptosis: an early event in metastatic inefficiency. Cancer Res 61 (2001) 333-338
34. Akhtar N., Padilla M., Dickerson E., et al. Interleukin-12 inhibits tumor growth in a novel angiogenesis canine hemangiosarcoma xenograft model. Neoplasia 6 (2004) 106-116
35. Dickerson E.B., Akhtar N., Steinberg H., et al. Enhancement of the antiangiogenic activity of interleukin-12 by peptide targeted delivery of the cytokine to αv/β3 integrin. Mol Cancer Res 2 (2004) 663-673